BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35675801)

  • 1. Genomic Features of Interstitial Deletions of Chromosome 9q in Acute Myeloid Leukemia.
    Qi Z; Wen KW; Ki A; Prakash S; Kogan S; Yu J
    Cytogenet Genome Res; 2022; 162(3):119-123. PubMed ID: 35675801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.
    Herold T; Metzeler KH; Vosberg S; Hartmann L; Jurinovic V; Opatz S; Konstandin NP; Schneider S; Zellmeier E; Ksienzyk B; Graf A; Krebs S; Blum H; Cristina Sauerland M; Büchner T; Berdel WE; Wörmann BJ; Mansmann U; Hiddemann W; Bohlander SK; Spiekermann K; Greif PA
    Genes Chromosomes Cancer; 2017 Jan; 56(1):75-86. PubMed ID: 27636548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted region.
    Naarmann-de Vries IS; Sackmann Y; Klein F; Ostareck-Lederer A; Ostareck DH; Jost E; Ehninger G; Brümmendorf TH; Marx G; Röllig C; Thiede C; Crysandt M
    Leuk Res; 2019 Jan; 76():15-23. PubMed ID: 30476680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.
    Sweetser DA; Peniket AJ; Haaland C; Blomberg AA; Zhang Y; Zaidi ST; Dayyani F; Zhao Z; Heerema NA; Boultwood J; Dewald GW; Paietta E; Slovak ML; Willman CL; Wainscoat JS; Bernstein ID; Daly SB
    Genes Chromosomes Cancer; 2005 Nov; 44(3):279-91. PubMed ID: 16015647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial deletion of 9q revisited.
    Kwong YL; Ha SY; Ching LM; Chan LC
    Leuk Lymphoma; 1993 Dec; 12(1-2):153-5. PubMed ID: 8161932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Del (9q) AML: clinical and cytological characteristics and prognostic implications.
    Peniket A; Wainscoat J; Side L; Daly S; Kusec R; Buck G; Wheatley K; Walker H; Chatters S; Harrison C; Boultwood J; Goldstone A; Burnett A
    Br J Haematol; 2005 Apr; 129(2):210-20. PubMed ID: 15813849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine mapping of breakpoints in two unrelated patients with rare overlapping interstitial deletions of 9q with mild dysmorphic features.
    Kulharya AS; Flannery DB; Norris K; Lovell C; Levy B; Velagaleti GV
    Am J Med Genet A; 2008 Sep; 146A(17):2234-41. PubMed ID: 18666229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant presence of trisomy 21 and del(9q) in acute myeloid leukemia.
    Kwong YL; Chan LC
    Cancer Genet Cytogenet; 1992 Nov; 64(1):92-4. PubMed ID: 1458456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical findings in cases with 9q deletion encompassing the 9q21.11q21.32 region.
    Tuğ E; Ergün MA; Perçin EF
    Turk J Pediatr; 2018; 60(1):94-98. PubMed ID: 30102487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
    Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
    Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
    Fröhling S; Schlenk RF; Krauter J; Thiede C; Ehninger G; Haase D; Harder L; Kreitmeier S; Scholl C; Caligiuri MA; Bloomfield CD; Döhner H; Döhner K
    Genes Chromosomes Cancer; 2005 Apr; 42(4):427-32. PubMed ID: 15645492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites.
    Hirst WJ; Czepulkowski B; Mufti GJ
    Cancer Genet Cytogenet; 1993 Jan; 65(1):51-7. PubMed ID: 8431916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of M2 acute myeloblastic leukemia associated with an interstitial 9q deletion.
    Lin CC; De Braekeleer M; Etches WS; Thay TY
    Cancer Genet Cytogenet; 1987 Jan; 24(1):177-80. PubMed ID: 3466670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial 9q- deletion in a case of acute myeloid leukemia-M2 arising from a granulocytic sarcoma.
    Lunde JH; Allen EF
    Cancer Genet Cytogenet; 1994 Dec; 78(2):239-41. PubMed ID: 7828160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal deletion of the long arm of chromosome 9 in acute promyelocytic leukemia with a cryptic PML/RAR alpha rearrangement.
    Yamamoto K; Hamaguchi H; Kobayashi M; Tsurukubo Y; Nagata K
    Cancer Genet Cytogenet; 1999 Sep; 113(2):120-5. PubMed ID: 10484977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia.
    Royer-Pokora B; Trost D; Müller N; Hildebrandt B; Germing U; Beier M
    Cancer Genet Cytogenet; 2006 May; 167(1):66-9. PubMed ID: 16682289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial 9q deletion is associated with CD7+ acute leukemia of myeloid and T lymphoid lineage.
    Ferrara F; Scognamiglio M; Di Noto R; Schiavone EM; Poggi V; Fiorillo A; Libertini R; Vicari L; Del Vecchio L; Sebastio L
    Leukemia; 1996 Dec; 10(12):1990-2. PubMed ID: 8946942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.
    Dayyani F; Wang J; Yeh JR; Ahn EY; Tobey E; Zhang DE; Bernstein ID; Peterson RT; Sweetser DA
    Blood; 2008 Apr; 111(8):4338-47. PubMed ID: 18258796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 9q deletions on the classification of patients with acute myeloid leukemia.
    Balk B; Haferlach T; Meggendorfer M; Kern W; Haferlach C; Stengel A
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2871-2874. PubMed ID: 30927073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.